BRITTANY MATHIS: Open Payments
NPI 1104522630 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 16 payments from 9 companies in 2025. Trend: 2023 $216 · 2024 $236 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $173 |
| E.R. Squibb & Sons, L.L.C. | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Medtronic, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Amgen Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: Barostim Neo System, VENASEAL, JASCAYD, FARXIGA, DUPIXENT, GLASSIA, NUCALA, TEZSPIRE.
Industry payments across AL — which companies pay providers there.
